Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Abgenix, Inc. (ABGX) -- Ignore unavailable to you. Want to Upgrade?

To: keokalani'nui who wrote (464)	10/18/2005 4:01:48 PM
From: mopgcw	Respond to of 590

I dont believe the leak theory. BTs in general have been weak, some more so than others... edit: in another words i agree with you..

To: keokalani'nui who wrote (464)	10/18/2005 6:26:00 PM
From: tuck	Read Replies (1) \| Respond to of 590

We're probably looking at noise in various ways here. Options activity has been huge. Wonder if it relates to folks rolling positions out another month, or betting news will come out before expiration. Both? I haven't looked closely at IVs, but you'd need a two point move to pay for an October straddle, and middling results -- which are quite possible -- makes that a somewhat dicey strategy, even if one knew results would be out before expiration. I think, whether ABX-EGF works or not, the best strategy, risk/reward-wise, is to wait for the news to come out and then go long. Then there's that hedge fund manager Peter once quoted as saying "short clinical trials" . . . Good luck to all. No direct position but my Mom has a bit of CEGE, so hoping for the best. Cheers, Tuck